Your browser doesn't support javascript.
loading
Part 4: Myelodysplastic syndromes-Treatment of low-risk patients with the 5q deletion.
Magalhães, Silvia Maria Meira; Velloso, Elvira Deolinda Rodrigues Pereira; Buzzini, Renata; Bernardo, Wanderley Marques.
Affiliation
  • Magalhães SMM; Hospital Universitário Walter Cantídio-Universidade Federal do Ceará (HUWC UFC), Fortaleza, CE, Brazil. Electronic address: silviamm@ufc.br.
  • Velloso EDRP; Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo (HC FMUSP), São Paulo, SP, Brazil; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
  • Buzzini R; Associação Médica Brasileira (AMB), São Paulo, SP, Brazil.
  • Bernardo WM; Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo (HC FMUSP), São Paulo, SP, Brazil; Associação Médica Brasileira (AMB), São Paulo, SP, Brazil.
Hematol Transfus Cell Ther ; 40(3): 274-277, 2018.
Article in En | MEDLINE | ID: mdl-30128438
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: Hematol Transfus Cell Ther Year: 2018 Document type: Article Country of publication: Brazil
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: Hematol Transfus Cell Ther Year: 2018 Document type: Article Country of publication: Brazil